PT - JOURNAL ARTICLE AU - Patress Ann Persons AU - Sophie Bersoux AU - Mary Helen Whited TI - Is your patient at risk for NAFLD? AID - 10.3949/ccjm.89a.22005 DP - 2022 Dec 01 TA - Cleveland Clinic Journal of Medicine PG - 719--727 VI - 89 IP - 12 4099 - http://www.ccjm.org/content/89/12/719.short 4100 - http://www.ccjm.org/content/89/12/719.full SO - Cleve Clin J Med2022 Dec 01; 89 AB - Nonalcoholic fatty liver disease (NAFLD) affects approximately 37% of US adults. The progression from nonalcoholic fatty liver with no inflammation to steatohepatitis with inflammation and progressive fibrosis is associated with substantial morbidity and mortality. The epidemic of NAFLD requires that primary care providers recognize at-risk patients and screen them. The authors review identifying individuals at risk, treatment options founded on lifestyle modification, and when to consider referring patients to a hepatologist.